Algeta schedules fourth quarter and full year 2012 results presentation, webcast and conference call

Algeta schedules fourth quarter and full year 2012 results presentation, 
webcast and conference call 
OSLO, NORWAY -- (Marketwire) -- 02/18/13 --  Algeta ASA (OSE:
ALGETA), a company focused on the development of novel targeted
cancer therapeutics, will announce its fourth
quarter and full year
2012 results on Thursday, 28 February 2013. A presentation
Algeta's senior management team to investors, analysts and the press
take place in Oslo at 10:00 CET. The presentation will also be
webcast live and can be accessed through where
questions can also be submitted during the presentation. 
The presentation will take place at 10:00 CET at: 
Haakon VIIs gate 1 
0161 Oslo 
Algeta's  senior management will  also host an  international
conference call at 14:30 CET/08:30 Eastern Time (US) (details below). 
To  participate in the conference call, please dial the appropriate
number below
five minutes prior to the call: 
US: +1 877 423 0830 
UK: +44 20 7153 9154 
Norway: +47 21 06 61 13 
Sweden: +46 8-506 443 86 
Denmark: +45 32 71 42 62 
Switzerland: +41 44 580 65 22 
Participant pin code: 434633# 
To access the replay, please dial: 
US: +1 877 679 2989 
UK: +44 20 3364 5196 
Norway: +47 23 50 02 03 
Sweden: +46 8-505 564 73 
Conference reference: 345360# 
A   replay   version   of   the  conference  call  will  also  be
available  at 
The  results report and the presentation  will be available at in the Investors section from 07:00 CET. 
About Algeta 
Algeta is a company focused on developing novel targeted therapies
for patients
with cancer based on its alpha-pharmaceutical platform.
The Company is headquartered in Oslo, Norway, and has a US
subsidiary, Algeta US, LLC, based in Cambridge, MA performing
commercial marketing operations in the US. Algeta is
listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information
Press release: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they ar
e solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Algeta ASA via Thomson Reuters ONE 
For further information, please contact: 
Mike Booth / Renate Birkeli
+47 23 00 67 32 
Communications & Corporate Affairs 
Media enquiries:
Mark Swallow
+44 207 638 9571 
Citigate Dewe Rogerson 
Knut Ekern
+47 22 04 82 00 
Gambit Hill & Knowlton 
Kari Watson
+1 781 235 3060 
MacDougall Biomedical Communications 
US investor enquiries: 
Tricia Swanson
+1 646 378 2953 
The Trout Group
Press spacebar to pause and continue. Press esc to stop.